PubRank

Tariq Sethi

Author PubWeight™ 40.92‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis. Am J Pathol 2008 2.83
2 Galectin-3 regulates myofibroblast activation and hepatic fibrosis. Proc Natl Acad Sci U S A 2006 2.75
3 Regulation of alternative macrophage activation by galectin-3. J Immunol 2008 2.28
4 Ly6Chi monocytes direct alternatively activated profibrotic macrophage regulation of lung fibrosis. Am J Respir Crit Care Med 2011 2.15
5 Regulation of transforming growth factor-β1-driven lung fibrosis by galectin-3. Am J Respir Crit Care Med 2011 2.09
6 Critical role of c-jun (NH2) terminal kinase in paracetamol- induced acute liver failure. Gut 2006 1.82
7 The regulation of inflammation by galectin-3. Immunol Rev 2009 1.76
8 Integrin activation by Fam38A uses a novel mechanism of R-Ras targeting to the endoplasmic reticulum. J Cell Sci 2010 1.45
9 Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function. Am J Pathol 2008 1.28
10 Mammalian NOTCH-1 activates beta1 integrins via the small GTPase R-Ras. J Biol Chem 2007 1.23
11 Human dendritic cells produce TGF-beta 1 under the influence of lung carcinoma cells and prime the differentiation of CD4+CD25+Foxp3+ regulatory T cells. J Immunol 2009 1.22
12 CD98hc (SLC3A2) interaction with beta 1 integrins is required for transformation. J Biol Chem 2004 1.22
13 CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist. Cancer Res 2014 1.12
14 Cross-linking CD98 promotes integrin-like signaling and anchorage-independent growth. Mol Biol Cell 2002 1.04
15 Sphingosine kinase: a point of convergence in the action of diverse neutrophil priming agents. J Immunol 2002 1.01
16 Extracellular matrix regulation of drug resistance in small-cell lung cancer. Clin Sci (Lond) 2002 1.01
17 The epithelial cell and lung cancer: the link between chronic obstructive pulmonary disease and lung cancer. Respiration 2011 0.98
18 Small cell lung cancer: the importance of the extracellular matrix. Int J Biochem Cell Biol 2004 0.91
19 Loss of the integrin-activating transmembrane protein Fam38A (Piezo1) promotes a switch to a reduced integrin-dependent mode of cell migration. PLoS One 2012 0.90
20 Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice. Glycobiology 2013 0.90
21 Tubular atrophy and interstitial fibrosis after renal transplantation is dependent on galectin-3. Transplantation 2012 0.89
22 Small cell lung cancer tumour cells induce regulatory T lymphocytes, and patient survival correlates negatively with FOXP3+ cells in tumour infiltrate. Int J Cancer 2012 0.89
23 The molecular and cellular biology of lung cancer: identifying novel therapeutic strategies. Br Med Bull 2010 0.88
24 Treatments in idiopathic pulmonary fibrosis: time for a more targeted approach? QJM 2012 0.87
25 Serum from patients with fulminant hepatic failure causes hepatocyte detachment and apoptosis by a beta(1)-integrin pathway. Hepatology 2004 0.84
26 Targeting growth factors in lung cancer. Chest 2008 0.82
27 Advances in Molecular Biology of Lung Disease: Aiming for Precision Therapy in Non-small Cell Lung Cancer. Chest 2015 0.80
28 Microdroplet digital PCR: detection and quantitation of biomarkers in archived tissue and serial plasma samples in patients with lung cancer. J Thorac Oncol 2015 0.79
29 Targeting V1A-vasopressin receptors with [Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) identifies a strategy to develop novel anti-cancer therapies. Br J Pharmacol 2009 0.78
30 [D-Arg6, D-Trp7,9, NmePhe8]-substance P (6-11) activates JNK and induces apoptosis in small cell lung cancer cells via an oxidant-dependent mechanism. Methods Mol Med 2003 0.78
31 Phospholipase C epsilon suppresses integrin activation. J Biol Chem 2006 0.77
32 Integrins and extracellular matrix: a novel mechanism of multidrug resistance. Expert Rev Anticancer Ther 2002 0.77
33 DNA methylation profiling of non-small cell lung cancer reveals a COPD-driven immune-related signature. Thorax 2015 0.75
34 Temporal expression of galectin-3 following myocardial infarction. Acta Cardiol 2014 0.75